Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey, Arthritis and rheumatism. Epub, vol.6330, issue.10, pp.3136-3177, 2007. ,
Refractory gout: what is it and what to do about it? Current opinion in rheumatology, Epub, vol.2020, issue.2, pp.198-202, 2008. ,
Difficult-to-Treat Gouty Arthritis, Drugs, vol.69, issue.6887, pp.1413-1452, 2011. ,
DOI : 10.1136/ard.2010.136218
A pilot study of IL-1 inhibition by anakinra in acute gout, Arthritis Research & Therapy, vol.9, issue.2, pp.28-17352828, 2007. ,
DOI : 10.1186/ar2143
Summary Minutes of the Arthritis Advisory Committee Meeting, 2011. ,
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis, Journal of Clinical Investigation, vol.116, issue.10, pp.2633-2675, 2006. ,
DOI : 10.1172/JCI28546.
Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases, Annals of Medicine, vol.35, issue.5, pp.362-369, 2003. ,
DOI : 10.1080/07853890310001339
Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis, Annals of the Rheumatic Diseases, vol.64, issue.8, pp.1126-1157, 2005. ,
DOI : 10.1136/ard.2004.029835
Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemia, Clinical Rheumatology, vol.22, issue.4-5 ,
DOI : 10.1007/s10067-003-0716-3
Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance Annual review of pharmacology and toxicology, Epub, vol.531010, pp.161-85, 2012. ,
Contribution of mast cellderived interleukin-1beta to uric Acid crystal-induced acute arthritis in mice, Arthritis & rheumatology, vol.6620, issue.1006, pp.2881-91, 2014. ,
Gout-associated uric acid crystals activate the NALP3 inflammasome, Nature, vol.20, issue.7081, pp.237-278, 2006. ,
DOI : 10.7326/0003-4819-62-4-648
URL : http://www.nature.com/nature/journal/v440/n7081/pdf/nature04516.pdf
Bioluminescence imaging of myeloperoxidase activity in vivo, Nature Medicine, vol.107, issue.4, pp.455-61, 2009. ,
DOI : 10.1042/bj3080559
Synaptotagmin-mediated vesicle fusion regulates cell migration, Nature Immunology, vol.31, issue.6, pp.495-502, 2010. ,
DOI : 10.4049/jimmunol.179.4.2223
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951881/pdf
IL-1beta, and gout: is there a link? Seminars in immunopathology, pp.501-513, 2013. ,
Not water, but formalin, dissolves urate crystals in tophaceous tissue samples, J Rheumatol, vol.21, issue.12, pp.2320-2321, 1994. ,
Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms, Oncogene, vol.22, issue.5, pp.660-664, 2003. ,
DOI : 10.1038/sj.onc.1206120
URL : https://hal.archives-ouvertes.fr/hal-00282566
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia, New England Journal of Medicine, vol.344, issue.14, pp.1031-1038, 2001. ,
DOI : 10.1056/NEJM200104053441401
Imatinib Mesylate Efficiently Achieves Therapeutic Intratumor Concentrations in Vivo but Has Limited Activity in a Xenograft Model of Small Cell Lung Cancer, Clinical Cancer Research, vol.10, issue.10 ,
DOI : 10.1158/1078-0432.CCR-0957-03